Verition Fund Management
SGMO

Verition Fund Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Verition Fund Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12,622
Closed -$62K – 2656
2022
Q3 		$62K Buy
+12,622
New +$64.8K ﹤0.01% 2679
2019
Q4 		– Sell
-118,573
Closed -$1.07M – 1336
2019
Q3 		$1.07M Buy
+118,573
New +$1.33M 0.03% 392
2014
Q2 		– Sell
-10,228
Closed -$185K – 770
2014
Q1 		$185K Buy
+10,228
New +$197K 0.03% 403

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Verition Fund Management's SGMO Position: Q4 2022 in Review

Verition Fund Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2022, closing a stake of 12,622 shares — an estimated $62K sold.

Verition Fund Management first reported a position in SGMO in Q1 2014 and held it in 3 quarters. The position peaked at $1.07M in Q3 2019. 182 funds tracked by Wall St. Rank hold SGMO as of Q4 2022.

  • Verition Fund Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2022 after selling out during the quarter.
  • Verition Fund Management sold 12,622 SANGAMO THERAPEUTICS INC shares in Q4 2022, an estimated $62K.
  • Verition Fund Management first reported a position in SANGAMO THERAPEUTICS INC in Q1 2014 and held it in 3 quarters.
  • Verition Fund Management's SANGAMO THERAPEUTICS INC position peaked at $1.07M in Q3 2019.
  • 182 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2022.

Based on Verition Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.